InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Celularity Inc

CELU Clue Score36
United States Fiscal year ends December CIK 0001752828
$1.56 +6.85% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.56 −77.03% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 8 Aug 2019. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2019Operating income−1.7Net income5.9Fiscal year 2020Revenue14.3Operating income−151.9Net income−208.2 −3,642.1%Fiscal year 2021Revenue21.3 +49.4%Operating income−109.1Net income−100.1EPS, diluted−1.49Fiscal year 2022Revenue18.0 −15.7%Operating income−25.6Net income14.2EPS, diluted0.95Fiscal year 2023Revenue22.8 +26.7%Operating income−192.3Net income−196.3 −1,483.1%EPS, diluted−11.02Fiscal year 2024Revenue54.2 +138.1%Operating income−38.4Net income−57.9EPS, diluted−2.64Fiscal year 2025Revenue26.6 −51.0%Operating income−61.3Net income−91.7EPS, diluted−3.59
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a 14.3 21.3 18.0 22.8 54.2 26.6
Growth +49.4% −15.7% +26.7% +138.1% −51.0%
Operating income −1.7 −151.9 −109.1 −25.6 −192.3 −38.4 −61.3
Net income 5.9 −208.2 −100.1 14.2 −196.3 −57.9 −91.7
Growth −3,642.1% −1,483.1%
EPS, diluted n/a n/a −1.49 0.95 −11.02 −2.64 −3.59

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2019Fiscal year 2020Gross margin65.5%Operating margin−1,064.0%Net margin−1,458.4%Free cash flow margin−637.5%Fiscal year 2021Gross margin54.8%Operating margin−511.2%Net margin−469.3%Free cash flow margin−545.1%Fiscal year 2022Gross margin−9.4%Operating margin−142.4%Net margin79.0%Free cash flow margin−796.2%Fiscal year 2023Gross margin29.7%Operating margin−844.4%Net margin−862.0%Free cash flow margin−174.5%Fiscal year 2024Operating margin−70.7%Net margin−106.8%Free cash flow margin−12.1%Fiscal year 2025Operating margin−230.9%Net margin−345.4%
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin n/a 65.5% 54.8% −9.4% 29.7% n/a n/a
Operating margin n/a −1,064.0% −511.2% −142.4% −844.4% −70.7% −230.9%
Net margin n/a −1,458.4% −469.3% 79.0% −862.0% −106.8% −345.4%
Free cash flow margin n/a −637.5% −545.1% −796.2% −174.5% −12.1% n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2019Operating cash flow−1.1Fiscal year 2020Operating cash flow−63.2Capital expenditure−27.8Free cash flow−91.0Buybacks−0.3Fiscal year 2021Operating cash flow−110.1Capital expenditure−6.2Free cash flow−116.3Fiscal year 2022Operating cash flow−137.9Capital expenditure−5.2Free cash flow−143.1Fiscal year 2023Operating cash flow−38.7Capital expenditure−1.0Free cash flow−39.7Fiscal year 2024Operating cash flow−6.4Capital expenditure−0.2Free cash flow−6.6Fiscal year 2025Operating cash flow−13.3
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −1.1 −63.2 −110.1 −137.9 −38.7 −6.4 −13.3
Capital expenditure n/a −27.8 −6.2 −5.2 −1.0 −0.2 n/a
Free cash flow n/a −91.0 −116.3 −143.1 −39.7 −6.6 n/a
Growth
Buybacks n/a −0.3 n/a n/a n/a n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2019Cash0.9Shareholders’ equity−327.4Fiscal year 2020Cash54.3Shareholders’ equity−531.4Fiscal year 2021Cash37.2Shareholders’ equity99.4Fiscal year 2022Cash14.0Shareholders’ equity198.9Fiscal year 2023Cash0.2Shareholders’ equity41.0Fiscal year 2024Cash0.7Shareholders’ equity8.8Fiscal year 2025Cash6.2Shareholders’ equity−38.1
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 0.9 54.3 37.2 14.0 0.2 0.7 6.2
Shareholders’ equity −327.4 −531.4 99.4 198.9 41.0 8.8 −38.1

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022† 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
n/a 14.3 21.3 18.0 22.8 54.2 26.6
Growth +49.4% −15.7% +26.7% +138.1% −51.0%
n/a n/a n/a n/a 16.0 15.0 20.1
n/a 9.3 11.7 −1.7 6.8 n/a n/a
Growth +25.0% −114.5%
n/a 52.7 88.4 78.4 30.5 17.4 15.0
n/a 31.3 71.3 66.0 50.6 58.6 51.3
−1.7 −151.9 −109.1 −25.6 −192.3 −38.4 −61.3
Growth
6.5 −212.9 −100.1 14.2 −196.3 −57.9 −91.7
0.7 −4.7 0.0 0.0 0.0 n/a 0.0
5.9 −208.2 −100.1 14.2 −196.3 −57.9 −91.7
Growth −3,642.1% −1,483.1%
Per share
n/a n/a −1.49 1.01 −11.02 −2.64 −3.59
n/a n/a −1.49 0.95 −11.02 −2.64 −3.59
Growth −1,260.0%
n/a n/a 67.1 14.0 17.8 21.9 25.6
n/a n/a 67.1 15.0 17.8 21.9 25.6
Growth −77.7% +18.9% +22.9% +16.9%

† The diluted share count jumps at 2022, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 13.2% a year over five years.
  • Operating margin is up 833.1 points on five years ago, at -230.9%.
  • A net loss in 5 of 7 years on file.